Drug search by name

Zolinza and Myelosuppression

Result of checking the interaction of drug Zolinza and disease Myelosuppression for safety when used together.

Check result:

Zolinza <> Myelosuppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of vorinostat can cause dose-related thrombocytopenia and anemia. It is recommended to monitor blood counts every 2 weeks during the first 2 months of therapy and monthly thereafter. Adjust dosage or discontinue treatment as clinically appropriate. Care should be exercised when using this agent in patients with bone marrow suppression.

Zolinza

Generic Name: vorinostat

Brand Name: Zolinza

Synonyms: n.a.

What is Zolinza?